Focal Laser Ablation of Prostate Cancer: Results in 120 Patients with Low- to Intermediate-Risk Disease.

ABSTRACT:

Purpose

Can focal laser ablation (FLA) of low to intermediate risk prostate cancer preserve sexual and urinary function with low morbidity while providing adequate oncologic outcomes.

Materials and methods

Transrectal FLA was done in 120 patients with low- to intermediate-risk prostate cancer. MR imaging thermometry controlled ablation. At 6 and 12 months, patients had clinical and MR imaging follow-up with biopsy of suspicious areas. Patients submitted surveys of sexual and urinary function. Multivariate logistic regression identified determinants of positive imaging and biopsies. Two-sided Wilcoxon signed rank test evaluated scores and laboratory values.

Results

Median patient age was 64 years, and median prostate-specific antigen (PSA) was 6.05 ng/mL. Median follow

SUBMITTER: Walser E 

PROVIDER: S-EPMC8503805 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature